首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro.
【2h】

Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro.

机译:通过检测体外扩增的白血病特异性mRNA序列诊断慢性髓样和急性淋巴细胞性白血病。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The Philadelphia chromosome is present in more than 95% of chronic myeloid leukemia patients and 13% of acute lymphocytic leukemia patients. The Philadelphia translocation, t(9;22), fuses the BCR and ABL genes resulting in the expression of leukemia-specific, chimeric BCR-ABL messenger RNAs. To facilitate diagnosis of these leukemias, we have developed a method of amplifying and detecting only the unique mRNA sequences, using an extension of the polymerase chain reaction technique. Diagnosis of chronic myeloid and acute lymphocytic leukemias by this procedure is rapid, much more sensitive than existing protocols, and independent of the presence or absence of an identifiable Philadelphia chromosome.
机译:费城染色体存在于超过95%的慢性粒细胞白血病患者和13%的急性淋巴细胞性白血病患者中。费城易位,t(9; 22),融合了BCR和ABL基因,导致白血病特异性嵌合BCR-ABL信使RNA的表达。为了促进这些白血病的诊断,我们开发了一种方法,使用聚合酶链反应技术的扩展仅扩增和检测独特的mRNA序列。通过这种方法诊断慢性髓细胞性白血病和急性淋巴细胞性白血病是快速的,比现有方案更敏感,并且与可识别的费城染色体的存在与否无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号